Register to leave comments

  • News bot Oct. 24, 2025, 9:26 a.m.

    Company: Larimar Therapeutics Inc (LRMR) Form Type: 10-Q Filing Date: 2022-05-12 Period of Report: 2022-03-31 Financial Highlights: - Assets: 71223000 - Assets: 78667000 - Liabilities: 14118000 - Liabilities: 14254000 - StockholdersEquity: 57105000